I earned my Ph.D. degree from College of Pharmaceutical Sciences, Suzhou University, Jiangsu Province, China and successfully published few research articles with co-workers in high impact journals. My research project is mainly focused on the LRP1 targeting nanoparticle’s clearance inhibition from brain, using a fusion peptide to target LRP1 receptors at blood-brain barrier, and treatment of brain metastases with doxorubicin and lapatinib combinatorial regimen, which I have been published in high impact Acta Pharmaceutica Sinica B. I have also published papers as co-author in Journal of control release, Acta Pharmaceutica Sinica B, ACS Applied Materials and Interfaces, International journal of biological macromolecules, Pharmaceutics, Materials, BMC medical genomics and few more. I have good scientific writing skills and also published two book chapters. I have also worked on other project that is based on nanoparticles brain delivery for the treatment of alzheimer's disease (AD), which is not yet published. I always showed deep enthusiasm for scientific research and learned many techniques like nanoparticles oriented drug delivery, synthesis of nanoparticles formulations, targeted therapy of cancer, targeted drug delivery across blood-brain barrier to the brain, cell culture, Flow cytometry, Confocal microscopy, pharmacokinetics, and pharmacodynamics studies in animals, tumor models in mice.